Ethambutol

Ethambutol
Chemical structure of ethambutol (top) and photo of ethambutol crystals (bottom)
Clinical data
Trade namesMyambutol, Etibi, Servambutol, others
Other names(2S,2’S)-2,2’-(Ethane-1,2-diyldiimino)dibutan-1-ol
AHFS/Drugs.comMonograph
License data
Routes of
administration
By mouth
ATC code
Legal status
Legal status
  • AU: S4 (Prescription only)
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Protein binding20–30%
Metabolismliver
Elimination half-life3–4 hours
Identifiers
  • (2S)-2-[2-[[(2S)-1-hydroxybutan-2-yl]amino]ethylamino]butan-1-ol
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.000.737
Chemical and physical data
FormulaC10H24N2O2
Molar mass204.314 g·mol−1
3D model (JSmol)
  • CC[C@@H](CO)NCCN[C@@H](CC)CO
  • InChI=1S/C10H24N2O2/c1-3-9(7-13)11-5-6-12-10(4-2)8-14/h9-14H,3-8H2,1-2H3/t9-,10-/m0/s1 Y
  • Key:AEUTYOVWOVBAKS-UWVGGRQHSA-N

Ethambutol (EMB, E) is a medication primarily used to treat tuberculosis. It is usually given in combination with other tuberculosis medications, such as isoniazid, rifampicin and pyrazinamide. It may also be used to treat Mycobacterium avium complex, and Mycobacterium kansasii. It is taken by mouth.

Common side effects include problems with vision, joint pain, nausea, headaches, and feeling tired. Other side effects include liver problems and allergic reactions. It is not recommended in people with optic neuritis, significant kidney problems, or under the age of five. Use during pregnancy or breastfeeding has not been found to cause harm. In the United States the FDA has raised concerns about eye issues in the baby if used during pregnancy. Ethambutol is believed to work by interfering with the bacteria's metabolism.

Ethambutol was discovered in 1961. It is on the World Health Organization's List of Essential Medicines and is available as a generic medication.